Medicare Enrolled

Dr. Joel Campbell

Neurology · Temple, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
2401 S 31ST ST, Temple, TX 76508
2547242111
In practice since 2014 (11 years)
NPI: 1104245992 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Campbell from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Campbell? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Campbell

Dr. Joel Campbell is a neurology in Temple, TX, with 11 years in practice. Based on federal Medicare data, Dr. Campbell performed 782 Medicare services across 580 unique beneficiaries.

Between the years covered by Open Payments, Dr. Campbell received a total of $13,594 from 75 pharmaceutical and/or device companies across 669 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Campbell is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice▲ Top 37% volume in TX$ $13,594 industry payments

Medicare Practice Summary

Medicare Utilization ↗
782
Medicare services
Top 37% in TX for neurology
580
Unique beneficiaries
$96
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~71 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)397$83$219
Hospital follow-up visit, high complexity147$91$266
Initial hospital admission, high complexity79$131$516
New patient office visit (45-59 min)64$113$247
Critical care, first 30-74 min54$163$950
Measurement of brain wave activity (eeg), awake and drowsy29$43$207
Initial hospital admission, moderate complexity12$100$319
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$13,594
Total received (2018-2024)
Avg $1,942/year across 7 years
Top 23% in TX for neurology
75
Companies
669
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,565 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$29 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$134
2023
$1,963
2022
$2,950
2021
$3,283
2020
$2,524
2019
$2,379
2018
$361

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Biogen, Inc.
$824
Novartis Pharmaceuticals Corporation
$720
Alexion Pharmaceuticals, Inc.
$662
UCB, Inc.
$627
Amgen Inc.
$553
AbbVie Inc.
$513
EMD Serono, Inc.
$481
GENZYME CORPORATION
$474
ACADIA Pharmaceuticals Inc
$457
Teva Pharmaceuticals USA, Inc.
$424
Lilly USA, LLC
$406
Genentech USA, Inc.
$402
Adamas Pharmaceuticals, Inc.
$364
SK Life Science, Inc.
$348
ABBVIE INC.
$347
Allergan, Inc.
$339
Avanir Pharmaceuticals, Inc.
$298
Biohaven Pharmaceuticals, Inc.
$293
Takeda Pharmaceuticals U.S.A., Inc.
$279
Supernus Pharmaceuticals, Inc.
$274
Grifols USA, LLC
$257
UPSHER-SMITH LABORATORIES LLC
$249
Sunovion Pharmaceuticals Inc.
$230
Abbott Laboratories
$219
Alnylam Pharmaceuticals Inc.
$204
Merz Pharmaceuticals, LLC
$175
Lundbeck LLC
$158
LivaNova USA, Inc.
$146
Neurocrine Biosciences, Inc.
$146
Kyowa Kirin, Inc.
$142
Eisai Inc.
$140
Janssen Pharmaceuticals, Inc
$139
Stryker Corporation
$134
ARGENX US, INC.
$127
Biohaven Pharmaceutical Holding Company Ltd.
$125
CSL Behring
$105
Bausch Health US, LLC
$105
MERZ NORTH AMERICA, INC.
$102
Upsher-Smith Laboratories LLC
$99
ARBOR PHARMACEUTICALS, INC.
$98
MITSUBISHI TANABE PHARMA AMERICA, INC.
$95
Amneal Pharmaceuticals LLC
$90
Sumitomo Pharma America, Inc.
$88
Greenwich Biosciences, Inc.
$77
Boston Scientific Corporation
$73
PFIZER INC.
$70
AQUESTIVE THERAPEUTICS, INC.
$65
Allergan Inc.
$64
Currax Pharmaceuticals LLC
$59
EISAI INC.
$51
Aprecia Pharmaceuticals, LLC
$43
BOSTON SCIENTIFIC CORPORATION
$43
IMPEL PHARMACEUTICALS INC.
$43
Promius Pharma LLC
$41
Otsuka America Pharmaceutical, Inc.
$38
Zyla Life Sciences, Inc.
$37
Merz North America, Inc.
$35
Celgene Corporation
$34
JAZZ PHARMACEUTICALS INC.
$30
Acorda Therapeutics, Inc
$29
Octapharma USA, Inc.
$29
GE HEALTHCARE
$28
BANNER LIFE SCIENCES, LLC
$26
Avion Pharmaceuticals
$23
NS Pharma, Inc.
$22
GE HealthCare
$20
US WorldMeds, LLC
$19
E.R. Squibb & Sons, L.L.C.
$19
Tactile Systems Technology Inc
$19
Vertical Pharmaceuticals, LLC
$18
Mallinckrodt Enterprises LLC
$17
Horizon Therapeutics plc
$17
Mallinckrodt Hospital Products Inc.
$17
Azurity Pharmaceuticals, Inc.
$14
GE Healthcare
$13
Top 3 companies account for 16.2% of total payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AEQUALIS PERFORM+ · AFINITOR · AIMOVIG · AJOVY · AMYVID · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BOTOX · Briviact · CONFIRM RX · DUOPA · Dhivy · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · Flexitouch Plus · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · Gamunex-C · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KYNMOBI · LATUDA · LEMTRADA · MAVENCLAD · MAYZENT · MIGRANAL · Mavenclad · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONPATTRO · ONZETRA XSAIL · OSMOLEX ER · OXTELLAR XR · Ongentys · PANZYGA · PLEGRIDY · Ponvory · QULIPTA · RADICAVA · REXULTI · RYTARY · SOLIRIS · SPRIX · SYMPAZAN · Soliris · Spritam · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Tosymra Sumatriptan Nasal Spray · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VERCISE · VILTEPSO · VNS Therapy · VUMERITY · VYEPTI · VYVGART · Vercise · Vimpat · WATCHMAN Access System · XARELTO · XCOPRI · XEOMIN · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $1,738 per 100 Medicare services performed
Looking for a neurology in Temple?
Compare neurologys in the Temple area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Campbell is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Campbell experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Campbell performed 397 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Campbell receive payments from pharmaceutical companies?
Yes. Dr. Campbell received a total of $13,594 from 75 companies across 669 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Campbell's costs compare to other neurologys in Temple?
Dr. Campbell's average Medicare payment per service is $96. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Campbell) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →